KGKhudaverdi Ganbarov

Khudaverdi Ganbarov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Khudaverdi Ganbarov has a total of 94 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Synthesis and Antibacterial Activity of Some Acetophenone Derivatives

    by Ibrahim G. Mamedov, Farid N. Naghiyev, Nurana F. Aliyeva, Victor N. Khrustalev, Khudaverdi G. Ganbarov


  • Safety Assessment of Probiotics and Postbiotics: A Critical Review

    by Samira Ranjbar, Reza Ghotaslou, Khudaverdi Ganbarov, Şükran Köse, Amin Abbasi, Hossein Samadi Kafil

    Probiotics and postbiotics are essential components of modern dietary supplements, recognized for their beneficial effects on human health. While probiotics positively influence gut microbiota, digestion, and immune responses, their safety remains a concern, particularly in immunocompromised individuals, due to risks such as infections, transfer of antibiotic resistance genes, and systemic complications. In contrast, postbiotics—defined as inanimate microorganisms and/or their cellular components—offer a safer alternative by providing similar health benefits without the risks associated with live microorganisms. However, safety assessments of postbiotics remain limited and must address critical issues such as cytotoxicity, impurity profiles, and dose–response uncertainties, which are currently underexplored in the literature. Their enhanced stability under various environmental conditions further supports their application in inhibiting foodborne pathogens and extending product shelf life. This review critically evaluates the safety profiles of probiotics and postbiotics, offering a balanced analysis of their benefits and limitations, with particular attention to emerging safety concerns, risk assessment criteria, and applications in food safety and human health. Despite their promising safety profile, widespread adoption of postbiotics is hindered by the absence of standardized safety protocols and long-term toxicological data. Future research should therefore prioritize establishing evidence-based safety criteria, optimizing dosage and formulation for both probiotics and postbiotics, and addressing existing knowledge gaps through rigorous, targeted clinical studies, especially in vulnerable populations. A comprehensive literature search was conducted using the ISI Web of Knowledge, PubMed, Medline, Embase, Cochrane Register of Controlled Trials (CENTRAL), and Scopus databases covering the period from 2000 to 2025.


  • Open Access

    Impact of Environmental Factors on the Production of Silver Nanoparticles by Saccharomyces Ellipsoideus BSU-XR1

    by Khudaverdi G. Ganbarov, Mirmusa M. Jafarov, Sanam İ. Huseynova, Muhammad Shoaib, Kamala S. Alkishiyeva

    Biosciences, Biotechnology Research Asia is an international, open access, peer reviewed research journal covering all aspects of Biosciences and Biotechnology field.


  • The Impact of Temperature on the Synthesis of Silver Nanoparticles by Candida macedoniensis

    by Mirmusa Jafarov, Khudaverdi Ganbarov, Ergin Kari̇ptaş, Sanam Huseynova, Sevinj Gulıyeva

    Nanoparticles are widely used in medical diagnosis and treatment, as carriers of drug preparations, in cosmetics, production packaging and transportation of foods and etc. Special attention is paid to the use of biological structures in the production of nanoparticles. The aim at the presented work was to investigate the influence of temperature on the formation of silver nanoparticles by Candida macedoniensis BSU-MI44. Wet biomass of yeast at AgNO3 solution, was incubated at 25, 30, 35, 40°C. The samples have been analyzed on the UV spectrometer, the scanning electron microscope and the X-ray spectroscope. Spectrophotometric analyses showed 410 nm wavelength (peak), characteristic for silver nanoparticles in samples incubated at 25 and 30°C. By increasing temperature, the formation of silver nanoparticles has weakened and has finally stopped. The optimum temperature was between 25-30°C for the production of silver nanoparticles and the formed nanoparticles were spherical at both temperatures. The sizes of silver nanoparticles formed at 25°C and 30°C were 65.6 and 14.2-22.9 nm. The sizes of the first ones have been 2.8-4.7 times larger than the sizes of the others. Correspondingly X- ray spectroscopic analyses of the obtained samples showed the characteristic absorption peak for silver nanoparticles formed at temperatures 25 and 30°C.


  • Postbiotics versus probiotics in early-onset colorectal cancer

    by Hadi Feizi, Andrey Plotnikov, Mohammad Ahangarzadeh Rezaee, Khudaverdi Ganbarov, Fadhil S. Kamounah, Sergei Nikitin, Hiva Kadkhoda, Pourya Gholizadeh, Pasquale Pagliano, Hossein Samadi Kafil

    Probiotics and postbiotics mechanisms of action and applications in early-onset colorectal cancer (EOCRC) prevention and treatment have significant importance but are a matter of debate and controversy. Therefore, in this review, we aimed to define the probiotics concept, advantages and limitations in comparison to postbiotics, and proposed mechanisms of anti-tumor action in EOCRC prevention and treatment of postbiotics. Biotics (probiotics, prebiotics, and postbiotics) could confer the health benefit by affecting the host gut microbiota directly and indirectly. The main mechanisms of action of probiotics in exerting anticancer features include immune system regulation, inhibition of cancer cell propagation, gut dysbiosis restoration, anticancer agents’ production, gut barrier function renovation, and cancer-promoting agents’ reduction. Postbiotics are suggested to have different mechanisms of action to restore eubiosis against EOCRC, including modulation of gut microbiota composition, gut microbial metabolites regulation, and intestinal barrier function improvement via different features such as immunomodulatory, anti-inflammatory, antioxidant, and anti-proliferative properties. A better understanding of postbiotics challenges and mechanism of action in therapeutic applications will allow us to sketch accurate trials in order to use postbiotics as bio-therapeutics in EOCRC.


  • Open Access

    Antimicrobial activity and time kill curve study of newly synthesized dialkyl carboxylate cyclohexane derivative; A novel anti-Pseudomonas aeruginosa compound

    by Aygun Israyilova, Muhammad Shoaib, Khudaverdi Ganbarov, Alakbar Huseynzada, Sarvinaz Hajiyeva, Arif Ismiyev

    Pseudomonas aeruginosa causes nosocomial infections, ventilator-associated pneumonia and high morbidity and mortality in immunocompromised and cystic fibrosis patients. Development of the high level of resistance to multiple antibiotics and lack of new drugs accentuate the need of new antimicrobial substances against this opportunistic pathogen. A novel dimethyl carboxylate cyclohexane derivative was synthesized and initially screened against four Gram-positive bacteria and four Gram-negative bacteria by agar well diffusion method. Minimum inhibitory concentration (MIC) was determined against all test pathogens using resazurin dye by broth microdilution method. Effect of test compound on growth curve of Pseudomonas aeruginosa BDU-49 was evaluated by turbidimetric method. Time kill assay was performed to assess bacteriostatic or bactericidal nature and relationship between the concentration of the test compound and the net growth rate of Pseudomonas aeruginosa BDU-49. Test compound exhibited better antimicrobial activity against Gram-negative bacteria. Pseudomonas aeruginosa BDU-49 was the most susceptible test culture with MIC 62.5 μg mL-1. The growth curves of Pseudomonas aeruginosa BDU-49 demonstrated that test compound could inhibit the growth and reproduction of bacteria. Time kill assay showed that test compound is bactericidal at 2× MIC and bacteriostatic at MIC. Overall, these data indicate that test substance could act as probable novel anti-Pseudomonas aeruginosa compound in future.


  • Open Access

    Peoples’ attitude toward COVID-19 vaccine, acceptance, and social trust among African and Middle East countries

    by Nasim Asadi Faezi, Pourya Gholizadeh, Moussa Sanogo, Amadou Oumarou, Maad Nasser Mohamed, Yacouba Cissoko, Mamadou Saliou Sow, Bakary Sayon Keita, Youssouf Ag Mohamed Baye, Pasquale Pagliano, et al.

    Background: To end the COVID-19 pandemic, a large part of the world must be immune to the virus by vaccination. Therefore, this study aimed to gauge intent to be vaccinated against COVID-19 among ordinary people and to identify attitudes towards vaccines and barriers for vaccine acceptance. Methods: The study population comprises 1880 people residing in different countries that answer a prepared questionnaire. The questionnaire topics are demographics, historical issues, participants’ attitudes and beliefs regarding vaccines, concerns, and vaccine hesitancy. Results: Attitudes and beliefs relating to vaccines in general, and the COVID-19 vaccine, were ascertained. Overall, 66.81% of the contributors would like to be vaccinated against COVID-19, while %33.19 did not intend to be vaccinated. Reasons for COVID-19 vaccine hesitancy included concern regarding vaccine side effects, fear of getting sick from the uptake of the vaccine, and the absence of accurate vaccine promotion news. Individuals with higher education believe that India (68.6%) produces the best vaccine (P<0.001), while healthcare workers think the Chinese vaccine (44.2%) is the best (P=0.020). Individuals with higher education have not been vaccinated, not be healthcare workers, and females were the most contributors to effective of the vaccine in reducing mortality from COVID-19 disease. Conclusion: Given the degree of hesitancy against COVID-19 vaccination, a multifaceted approach to facilitate vaccine uptake that includes vaccine education, behavioral change strategies, and health promotion, is paramount.


  • Potential Pharmaceutical and Food Applications of Postbiotics: A Review

    by Aziz Homayouni Rad, Amin Abbasi, Hossein Samadi Kafil, Khudaverdi Ganbarov

    In recent decades, functional foods with ingredients comprising probiotics, prebiotics and postbiotics have been gaining a lot of attention from scientists. Probiotics and postbiotics are usually applied in pharmaceutical formulations and/or commercial food-based products. These bioactive agents can be associated with host eukaryotic cells and have a key role in maintaining and restoring host health. The review describes the concept of postbiotics, their quality control and potential applications in pharmaceutical formulations and commercial food-based products for health promotion, prevention of disease and complementary treatment. Despite the effectiveness of probiotic products, researchers have introduced the concept of postbiotic to optimize their beneficial effects as well as to meet the needs of consumers to provide a safe product. The finding of recent studies suggests that postbiotics might be appropriate alternative agents for live probiotic cells and can be applied in medical, veterinary and food practice to prevent and to treat some diseases, promote animal health status and develop functional foods. Presently scientific literature confirms that postbiotics, as potential alternative agents, may have superiority in terms of safety relative to their parent live cells, and due to their unique characteristics in terms of clinical, technological and economical aspects, can be applied as promising tools in the drug and food industry for developing health benefits, and therapeutic aims.


  • Open Access

    Alteration of Liver Biomarkers in Patients with SARS-CoV-2 (COVID-19)

    by Pourya Gholizadeh, Rohollah Safari, Parham Marofi, Elham Zeinalzadeh, Pasquale Pagliano, Khudaverdi Ganbarov, Silvano Esposito, Ehsaneh Khodadadi, Mehdi Yousefi, Hossein Samadi Kafil

    Introduction: Coronavirus disease 2019 (COVID-19) emerged in China and spread worldwide. In this study, we assessed the characteristics of markers of the liver in patients with COVID-19 to provide new insights in improving clinical treatment. Patients and Methods: We recruited 279 patients who confirmed COVID-19 and the data of liver biomarkers and complete blood count of patients were defined as the day onset when the patients admitted to the hospital. Results: The average of LDH value was 621.29 U/L in all patients with COVID-19, and CPK was 286.90 U/L. The average AST was 44.03 U/L in all patients, and ALT was 31.14 U/L. The AST/ALT ratio was 1.64 in all patients. The measurement of CRP was increased by 79.93% in all patients. Average ALT and AST values of patients with elevated ALT were significantly increased in comparison to patients with normal ALT (P-value = 0.001), while AST/ALT ratio was significantly decreased compared to patients with normal ALT (P-value= 0.014). In addition, the average LDH of patients with elevated ALT was significantly increased compared to patients with normal ALT (P-value = 0.014). Conclusion: Hepatic injury and abnormal liver enzymes related to COVID-19 infection is an acute non-specific inflammation alteration.


  • Open Access

    Proteomic Applications in Antimicrobial Resistance and Clinical Microbiology Studies

    by Ehsaneh Khodadadi, Elham Zeinalzadeh, Sepehr Taghizadeh, Bahareh Mehramouz, Fadhil S Kamounah, Ehsan Khodadadi, Khudaverdi Ganbarov, Bahman Yousefi, Milad Bastami, Hossein Samadi Kafil

    Sequences of the genomes of all-important bacterial pathogens of man, plants, and animals have been completed. Still, it is not enough to achieve complete information of all the mechanisms controlling the biological processes of an organism. Along with all advances in different proteomics technologies, proteomics has completed our knowledge of biological processes all around the world. Proteomics is a valuable technique to explain the complement of proteins in any organism. One of the fields that has been notably benefited from other systems approaches is bacterial pathogenesis. An emerging field is to use proteomics to examine the infectious agents in terms of, among many, the response the host and pathogen to the infection process, which leads to a deeper knowledge of the mechanisms of bacterial virulence. This trend also enables us to identify quantitative measurements for proteins extracted from microorganisms. The present review study is an attempt to summarize a variety of different proteomic techniques and advances. The significant applications in bacterial pathogenesis studies are also covered. Moreover, the areas where proteomics may lead the future studies are introduced.